Medicine & Life Sciences
Acute Kidney Injury
100%
Kidney
67%
Kidney Diseases
62%
Nephrology
55%
Neoplasms
48%
Multiple Myeloma
40%
Hyponatremia
39%
Chronic Renal Insufficiency
34%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
34%
Kidney Neoplasms
33%
Dialysis
31%
Dasatinib
29%
Leukemia, Myeloid, Chronic Phase
29%
Critical Illness
27%
Hybrid Renal Replacement Therapy
26%
Imatinib Mesylate
26%
trifluridine tipiracil
26%
Incidence
25%
bosutinib
25%
Mortality
24%
Tolvaptan
23%
Cidofovir
21%
Erythema elevatum diutinum
21%
Glomerular Filtration Rate
21%
Paraproteins
21%
BK Virus
20%
Schoenlein-Henoch Purpura
20%
Hematologic Neoplasms
19%
Safety
19%
Interstitial Nephritis
19%
Creatinine
19%
Therapeutics
19%
Philadelphia Chromosome
19%
Odds Ratio
18%
Emergencies
17%
Herpes Simplex
17%
Acute Tubulointerstitial Nephritis
17%
Nephrologists
17%
Myelodysplastic Syndromes
16%
Survival
16%
Renal Insufficiency
16%
Cell Transplantation
16%
Allogeneic Cells
16%
Hematopoietic Stem Cell Transplantation
15%
Immunocompromised Host
15%
Wounds and Injuries
15%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15%
Oncologists
15%
Length of Stay
14%